Tenax Therapeutics (TENX) Short-Term Debt repayments (2011 - 2015)
Tenax Therapeutics (TENX) posted quarterly Short-Term Debt repayments of $172025.0 for Q1 2015, up 103.62% year-over-year from $84483.9 in Q1 2014, and up 103.62% on a QoQ basis from -$4.8 million in Q1 2014.
Tenax Therapeutics (TENX) Short-Term Debt repayments (2011 - 2015) Analysis & Trends
Tenax Therapeutics has reported Short-Term Debt repayments for 5 years, with the latest figure at $172025.0 in Q1 2015.
- Short-Term Debt repayments for Q1 2015 came in at $172025.0, up 103.62% year-over-year; the trailing twelve-month figure through Dec 2015 was $172025.0 (changed N/A YoY), and the FY2015 annual result was $172025.0, up 21.73% from the prior year.
- Short-Term Debt repayments rose to $172025.0 in Q1 2015, from -$4.8 million in the prior quarter.
- Over five years, Short-Term Debt repayments peaked at $4.9 million in Q3 2013 and troughed at -$4.8 million in Q1 2014.
- A 5-year average of $627045.4 and a median of $172025.0 in 2015 frame the typical range for Short-Term Debt repayments.
- The widest annual swing landed in 2014, when Short-Term Debt repayments tumbled 4730.2%; it then jumped 103.62% in 2015.
- A 5-year view of Short-Term Debt repayments shows it stood at $700000.0 in 2011, then slumped by 80.33% to $137692.0 in 2012, then plunged by 118.15% to -$24995.0 in 2013, then tumbled by 18919.28% to -$4.8 million in 2014, then soared by 103.62% to $172025.0 in 2015.
- Per Business Quant data, the three most recent Short-Term Debt repayments figures were $172025.0 in Q1 2015, -$4.8 million in Q1 2014, and -$24995.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ST Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2015 | 172,025.00 |
| Jan 31, 2015 | 172,025.00 |
| Jan 31, 2014 | -4.75 Mn |
| Jan 31, 2014 | -4.75 Mn |
| Oct 31, 2013 | -24,995.00 |
| Oct 31, 2013 | -24,995.00 |
| Jul 31, 2013 | 4.92 Mn |
| Jul 31, 2013 | 4.92 Mn |
| Jan 31, 2013 | 102,671.00 |
| Jan 31, 2013 | 102,671.00 |
| Jan 31, 2012 | 137,692.00 |
| Jan 31, 2012 | 137,692.00 |
| Jul 31, 2011 | 700,000.00 |
| Jul 31, 2011 | 700,000.00 |
| Apr 30, 2011 | 2.30 Mn |
| Apr 30, 2011 | 2.30 Mn |
| Jan 31, 2011 | 2.09 Mn |
| Jan 31, 2011 | 2.09 Mn |